Rare association of herpes simplex virus IgM-specific antibodies and Guillain-Barré syndrome successfully treated with plasma exchange and immunosuppression. 1985

G Gerken, and F Trautmann, and H Köhler, and D Falke, and J Bohl, and W Nix, and K H Meyer zum Büschenfelde

Herpes simplex virus (HSV) has been associated with various neurological disorders. In contrast, HSV infection is very rarely found in acute polyneuroradiculitis. In this report, a patient is described with a severe course of Guillain-Barr¿ syndrome (GBS). HSV IgM-specific antibodies and a rise of complement-fixation antibodies were detected. During the acute phase of neurologic syndrome, a nerve biopsy showed myelin damage and IgM deposits on the inner layer of the perineurium. Plasma exchange, in combination with immunosuppression, was successfully applied as a treatment in the relapsing course of GBS. Finally, after recovery, HSV-specific IgM antibodies disappeared.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008297 Male Males
D009431 Neural Conduction The propagation of the NERVE IMPULSE along the nerve away from the site of an excitation stimulus. Nerve Conduction,Conduction, Nerve,Conduction, Neural,Conductions, Nerve,Conductions, Neural,Nerve Conductions,Neural Conductions
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D011129 Polyradiculoneuropathy Diseases characterized by injury or dysfunction involving multiple peripheral nerves and nerve roots. The process may primarily affect myelin or nerve axons. Two of the more common demyelinating forms are acute inflammatory polyradiculopathy (GUILLAIN-BARRE SYNDROME) and POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING. Polyradiculoneuritis refers to inflammation of multiple peripheral nerves and spinal nerve roots. Autoimmune Demyelinating Disease, Peripheral,Demyelinating Autoimmune Disease, Peripheral,Demyelinating Disease, Peripheral Autoimmune,Peripheral Autoimmune Demyelinating Disease,Polyradiculoneuritis,Polyradiculoneuritides,Polyradiculoneuropathies
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

G Gerken, and F Trautmann, and H Köhler, and D Falke, and J Bohl, and W Nix, and K H Meyer zum Büschenfelde
September 1977, Acta neurologica Scandinavica,
G Gerken, and F Trautmann, and H Köhler, and D Falke, and J Bohl, and W Nix, and K H Meyer zum Büschenfelde
January 1982, Vox sanguinis,
G Gerken, and F Trautmann, and H Köhler, and D Falke, and J Bohl, and W Nix, and K H Meyer zum Büschenfelde
January 2014, Asian journal of transfusion science,
G Gerken, and F Trautmann, and H Köhler, and D Falke, and J Bohl, and W Nix, and K H Meyer zum Büschenfelde
January 1975, British medical journal,
G Gerken, and F Trautmann, and H Köhler, and D Falke, and J Bohl, and W Nix, and K H Meyer zum Büschenfelde
February 1987, Harefuah,
G Gerken, and F Trautmann, and H Köhler, and D Falke, and J Bohl, and W Nix, and K H Meyer zum Büschenfelde
September 1991, No to hattatsu = Brain and development,
G Gerken, and F Trautmann, and H Köhler, and D Falke, and J Bohl, and W Nix, and K H Meyer zum Büschenfelde
January 1990, Annales de medecine interne,
G Gerken, and F Trautmann, and H Köhler, and D Falke, and J Bohl, and W Nix, and K H Meyer zum Büschenfelde
July 1985, Lancet (London, England),
G Gerken, and F Trautmann, and H Köhler, and D Falke, and J Bohl, and W Nix, and K H Meyer zum Büschenfelde
August 1989, Journal of the Royal Society of Medicine,
G Gerken, and F Trautmann, and H Köhler, and D Falke, and J Bohl, and W Nix, and K H Meyer zum Büschenfelde
September 1981, British medical journal (Clinical research ed.),
Copied contents to your clipboard!